Imunon, Inc. Current Liabilities
Imunon, Inc. (IMNN) had Current Liabilities of $4.78 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Liabilities, Current $4.78M.
- 2026-03-31: Liabilities, Current $4.17M.
- 2025-12-31: Liabilities, Current $4.62M.
- 2025-09-30: Liabilities, Current $4.20M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.78M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $4.17M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $4.62M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $4.20M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.32M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $5.80M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $4.79M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $5.44M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.08M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $4.82M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $7.39M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $5.32M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $6.12M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $10.42M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $10.04M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $8.46M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.89M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $6.65M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $6.77M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $6.48M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $5.38M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.69M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $6.75M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $5.43M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $9.21M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $7.43M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $7.89M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $7.79M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $6.65M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $5.89M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $6.11M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $5.80M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.24M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.63M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $6.20M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $6.00M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $6.96M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $8.84M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $8.42M 10-K · filed 2018-03-27 | |
| 2016-09-30 | $9.76M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $10.41M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $9.56M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $9.32M 10-K · filed 2017-03-24 | $9.35M 10-K · filed 2016-03-30 |
| 2015-09-30 | $8.43M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $9.80M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $10.29M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $10.09M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $9.41M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $7.77M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $5.25M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.67M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $6.09M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $5.71M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $7.66M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.01M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $6.61M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $6.69M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $6.40M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $6.15M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $4.64M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $5.14M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $6.80M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |